These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29362509)

  • 1. Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis.
    Misra MK; Damotte V; Hollenbach JA
    Genes Immun; 2019 Jan; 20(1):46-55. PubMed ID: 29362509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.
    Mamedov A; Vorobyeva N; Filimonova I; Zakharova M; Kiselev I; Bashinskaya V; Baulina N; Boyko A; Favorov A; Kulakova O; Ziganshin R; Smirnov I; Poroshina A; Shilovskiy I; Khaitov M; Sykulev Y; Favorova O; Vlassov V; Gabibov A; Belogurov A
    Front Immunol; 2019; 10():3088. PubMed ID: 32010139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.
    Mamedov AE; Zakharova MY; Favorova OO; Kulakova OG; Boyko AN; Knorre VD; Vorobieva NA; Khurs EN; Kiselev IS; Baulina NM; Gabibov AG; Belogurov AA
    Dokl Biochem Biophys; 2019 Mar; 485(1):115-118. PubMed ID: 31201628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex.
    Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29867033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
    Kumar A; Melis P; Genna V; Cocco E; Marrosu MG; Pieroni E
    Mol Biosyst; 2014 Aug; 10(8):2043-54. PubMed ID: 24853027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino acid variation within the binding pocket 7 and 9 of HLA-DRB1 molecules are associated with primary Sjögren's syndrome.
    Huang R; Yin J; Chen Y; Deng F; Chen J; Gao X; Liu Z; Yu X; Zheng J
    J Autoimmun; 2015 Feb; 57():53-9. PubMed ID: 25582848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
    Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
    Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    Smith KJ; Pyrdol J; Gauthier L; Wiley DC; Wucherpfennig KW
    J Exp Med; 1998 Oct; 188(8):1511-20. PubMed ID: 9782128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01.
    Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients.
    Teutsch SM; Bennetts BH; Buhler MM; Heard RN; Stewart GJ
    Hum Immunol; 1999 Aug; 60(8):715-22. PubMed ID: 10439317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modelling of frequent HLA class-II alleles: A perspective to improve prediction of HLA binding peptide and understand the HLA associated disease susceptibility.
    Kashyap M; Farooq U; Jaiswal V
    Infect Genet Evol; 2016 Oct; 44():234-244. PubMed ID: 27421208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II polymorphism in Latin American patients with multiple sclerosis.
    Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
    Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
    Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
    Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.